Article Summary
李争鸣周秀萍林梅李秀萍.口服卡介菌诱导免疫耐受的CD4+CD25+调节性T 细胞机制研究[J].现代生物医学进展英文版,2012,12(12):2278-2281.
口服卡介菌诱导免疫耐受的CD4+CD25+调节性T 细胞机制研究
Studies on CD4+CD25+ T Regulatory Cells in Immune ToleranceInduced by Oral BCG*
  
DOI:
中文关键词: 卡介菌  免疫耐受  实验性变态反应性脑脊髓炎  CD4+CD25+T 淋巴细胞
英文关键词: BCG  Immune tolerance  EAE  CD4+CD25+T regulatory cell
基金项目:湖南省教育厅课题资助项目(06C069)
Author NameAffiliation
LI Zheng-ming, ZHOU Xiu-ping, LI Mei, LI Xiu-ping 怀化医学高等专科学校 
Hits: 896
Download times: 0
中文摘要:
      目的:研究口服卡介菌诱导免疫耐受对CD4+CD25+ 调节性T 细胞的影响。方法:采用口服MPB 制备EAE 大鼠模型,随机分 为BCG 组(0.5mg/kg)和EAE 模型组(PBS),每组各15 只,连续经口灌服给药14d,同时选取15 只健康大鼠作为对照组。分别于 免疫后15d、27d 流式细胞术检测外周血、胸腺及脾脏中CD4+CD25+T 淋巴细胞百分率,ELISA 检测血清IL-6、TGF-β、IgE、IgG 含 量。结果:与EAE 模型组相比,免疫后BCG 组大鼠外周血、胸腺及脾脏中CD4+CD25+T 淋巴细胞百分率增加,血清IL-6、TGF-β 含量上升,血清IgE、IgG 抗体水平下降。结论:口服BCG 通过上调淋巴器官中CD4+CD25+T 淋巴细胞比例,抑制效应性T 细胞活 性,发挥免疫耐受作用。
英文摘要:
      Objective: To investigate the influence of oral BCG on CD4+ CD25+ T regulatory cells in inducing immune tolerance. Methods: The EAE rats, induced by immunization with oral MBP, were randomly divided into BCG group (0.5mg/kg) and EAE group (PBS), with 15 rats per group, and 15 normal rats were used as control group. On 15d and 27d after treatment, CD4+ CD25+ T regulatory cells from peripheral blood, thymus and spleen were respectively determined by flow cytometry, and levels of serum IL-6, TGF-β, IgE and IgG were measured by ELISA. Results: Compared with EAE group, CD4+ CD25+ T regulatory cells from peripheral blood, thymus and spleen, and levels of IL-6 and TGF-β increased in BCG group after treatment, but serum IgE and IgG levels decreased. Conclusion: Oral BCG could induce immune tolerance by up-regulating the percentage of CD4+ CD25+ T regulatory cells, inhibiting effector T cell function.
View Full Text   View/Add Comment  Download reader
Close